|
The State of Adjuvant Therapy of Colon Cancer in Germany 1999. |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
Consulting or Advisory Role - AMGEN; Celgene; Genomic Health International; Novartis Canada Pharmaceuticals Inc; Shire |
| |
|
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Merck; Novartis; Roche |
Speakers' Bureau - Bristol-Myers Squibb; Merck |
| |
|
Travel, Accommodations, Expenses - Boehringer Ingelheim |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
Consulting or Advisory Role - Celgene; Ipsen; Lilly |